Heart Hospital Of Austin

Details

Name :

Heart Hospital Of Austin

Address  :

3801 North Lamar Boulevard

Town  :

Austin

State  :

Texas

Country  :

USA

Post Code:

78756

Phone  :

512 407 7000

Web URL  :


Description

Ranked 1 in Texas for Cardiac Services 6 years in a row
Each year heart disease kills more people than any other disease As much as 40 percent of every healthcare dollar is spent fighting the problem The Heart Hospital of Austins solution is simple Our approach is comprehensive costeffective physicianled and patientfocused And all our resources are dedicated to keeping the heart healthy and treating it when its not

Designed by cardiologists and surgeons Heart Hospital of Austin is a threestory 138000 square foot 58bed facility In 1998 Heart Hospital of Austin opened its doors and began providing cardiovascular services to the people of Central Texas Since then our facility staff and services have grown and so has our reputation Today people come from across the nation to experience the benefits of a facility devoted to cardiac care

Our Mission
Heart Hospital of Austin in partnering with our physicians and associates is committed to enhancing the quality of health for our patients and their families by providing the highest personal service and delivering technologically advanced cardiovascular care through a compassionate patientfocused approach

Our Vision
quotTo be the premier provider of cardiovascular services by putting our hearts into caring for yoursquot

Our Values
Honor
Excellence
Accountability
Respect
Trust
Christiana Care Health System Skanska USA Top Out 215M Wilmington DE Hospital

Christiana Care Health System commemorated the structural completion of its new Wilmington Hospital during a topping out ceremony on Thursday April 12 on the top floor of the public parking garage on the hospitals campus The 215 million expansion includes a 386000squarefoot facility with a 10story patient tower and plaza that will feature new me... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More